Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Musculoskeletal Pain – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Musculoskeletal Pain market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Musculoskeletal Pain market report provides current treatment practices, emerging drugs, Musculoskeletal ... Read More
-
Nerve Growth Factor – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Nerve Growth Factor market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Nerve Growth Factor market report provides current ... Read More
-
Papilloma – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Papilloma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Papilloma market report provides current treatment practices, emerging drugs, Papilloma market share of the individual ... Read More
-
Sleep Apnea – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Sleep Apnea market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Sleep Apnea market report provides current treatment practices, emerging drugs, Sleep ... Read More
-
Tardive Dyskinesia – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Tardive Dyskinesia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Tardive Dyskinesia market report provides current treatment practices, emerging drugs, Tardive ... Read More
-
Testicular cancer – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Testicular cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Testicular cancer market report provides current treatment practices, emerging drugs, Testicular ... Read More
-
Turner Syndrome – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Turner Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Turner Syndrome market report provides current treatment practices, emerging drugs, Turner ... Read More
-
X Linked Hypophosphatemia – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the X Linked Hypophosphatemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The X Linked Hypophosphatemia market report provides current ... Read More
-
Hypersomnia – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Hypersomnia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Hypersomnia market report provides current treatment practices, emerging drugs, Hypersomnia market share of the individual ... Read More
-
Hypovolemic Shock – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Hypovolemic Shock market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Hypovolemic Shock market report provides current treatment practices, emerging drugs, Hypovolemic ... Read More
-
Mucopolysaccharidosis – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Mucopolysaccharidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Mucopolysaccharidosis market report provides current treatment practices, emerging drugs, Mucopolysaccharidosis market share of the individual ... Read More
-
Nonalcoholic Steatohepatitis (NASH) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Nonalcoholic Steatohepatitis (NASH) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Nonalcoholic Steatohepatitis (NASH) market report provides current ... Read More
-
Bone Resorption – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Bone Resorption market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Bone Resorption market report provides current treatment practices, emerging drugs, Bone ... Read More
-
BRAF-Mutant Metastatic Melanoma – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the BRAF-Mutant Metastatic Melanoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The BRAF-Mutant Metastatic Melanoma market report provides current ... Read More
-
North America Hypophosphatasia Treatment Market
... of 2024 to 2031. Market Segmentation North America Hypophosphatasia Treatment Market, By Types (Odontohypophosphatasia, Pseudohypophosphatasia, and Others), Therapy Type (Enzyme Replacement Therapy and Supportive Therapy), Route of Administration (Injectable and Oral), End User (Hospitals, Speciality ... Read More
-
Ovarian Granulosa Cell Tumors – Market Insight, Epidemiology, and Market Forecast – 2034
... Granulosa Cell Tumors, historical and forecasted epidemiology as well as the Ovarian Granulosa Cell Tumors market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Ovarian Granulosa Cell ... Read More
-
Japan Mental Health Market Overview, 2029
... larger healthcare system in recent years. This dynamic terrain is an interesting and diverse subject of study since it is impacted by a multitude of elements, from cultural beliefs to economic realities. Japan, a country ... Read More
-
Rare Diseases Market Report 2024-2034
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Advancements in R&D and Regulatory Incentives Driving Market Growth The ... Read More
-
Skeletal Dysplasia Drugs Market - By Dysplasia Type (Morquio A Syndrome, X-linked Hypophosphatemia, Hypophosphatasia, Achondroplasia), Treatment (Enzyme Replacement Therapy, Human Monoclonal Antibody), Distribution Channel – Global Forecast (2024 – 2032)
... is projected to witness 4.2% CAGR between 2024 and 2032 driven by the increasing prevalence and diagnosis of skeletal dysplasia. As per reports, non-lethal skeletal dysplasia occurs in approximately 1 in 26,000 to 1 in ... Read More
-
MELAS Syndrome: Competitive Landscape
... anticipated in 2024 in the 16 countries covered in GlobalData’s epidemiology forecast for MELAS Syndrome. There is no FDA approved innovator therapy available in the market for treatment of MELAS Syndrome. The pipeline for MELAS ... Read More
-
Global Endocrinology Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... 2023 and is forecast to a readjusted size of USD 140400 million by 2030 with a CAGR of 5.0% during review period. Endocrinology drugs are used to treat hormonal problems such as hypothyroidism, diabetes and ... Read More
-
Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update
... Sclerosis (ALS) market through 2029. The prevalence of ALS is increasing at a steady rate, in line with population growth in the 8MM, at an annual growth rate (AGR) of 0.79%.The diagnosed prevalent cases of ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032
... (ADHD) market through 2032. The prevalent cases of ADHD in the 7MM will increase from 21,141,036 to 21,970,997, at an annual growth rate (AGR) of 0.4% over the forecast period. The ADHD market was valued ... Read More
-
Global Endocrinology Drugs Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Gonorrhea Therapeutics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
Research Assistance
